Fibroblast Activation Protein and Tertiary Lymphoid Structure in Colorectal Cancer Recurrence.
By: Shimon Hayase, Norikatsu Miyoshi, Shiki Fujino, Masayoshi Yasui, Masayuki Ohue, Soichiro Minami, Shinya Kato, Ayumi Nagae, Yuki Sekido, Tsuyoshi Hata, Atsushi Hamabe, Takayuki Ogino, Hidekazu Takahashi, Mamoru Uemura, Hirofumi Yamamoto, Yuichiro Doki, Hidetoshi Eguchi

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
2022-10-13; doi: 10.21873/anticanres.16099
Abstract

Background/aim

Fibroblast activation protein (FAP) is known to have prognostic significance in colorectal cancer (CRC). However, FAP and tertiary lymphoid structures (TLSs) have not been associated with each other in predicting the prognosis of CRC recurrence.

Patients

FAP expression was evaluated by real-time reverse transcription polymerase chain reaction in 195 CRC patients at Osaka International Cancer Institute (first data set). Immunohistochemistry (IHC) was then performed to stain FAP at the invasive margin (IM) and in the central tumour (CT) in 159 CRC patients at Osaka University Hospital (second data set). Consecutive slides were used to evaluate the presence of TLSs in 159 CRC patients from Osaka University Hospital.

Results

The high FAP mRNA expression group (n=82) was associated with poor recurrence-free survival (RFS) compared with the low FAP expression group (n=83) (p=0.004). In the second data set, patients with high FAP expression in CT and TLS absence (n=49) showed significantly poorer RFS compared with those with low expression of FAP in CT and presence of TLSs (n=101) (p=0.002).

Conclusion

FAP in the CT combined with TLSs was shown to have significant prognostic value in predicting CRC recurrence after curative resection.



Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

PMID:36456145






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements